Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Mobile ECG Devices Market, by Modality
1.4.2 Asia Pacific Mobile ECG Devices Market, by End-use
1.4.3 Asia Pacific Mobile ECG Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Apr – 2023, Oct) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. Asia Pacific Mobile ECG Devices Market, by Modality
5.1 Asia Pacific Handheld Market, by Country
5.2 Asia Pacific Band Market, by Country
5.3 Asia Pacific Pen Market, by Country
5.4 Asia Pacific Others Market, by Country
Chapter 6. Asia Pacific Mobile ECG Devices Market, by End-use
6.1 Asia Pacific Hospitals & Diagnostic Centers Market, by Country
6.2 Asia Pacific Ambulatory Care Market, by Country
6.3 Asia Pacific Homecare Market, by Country
Chapter 7. Asia Pacific Mobile ECG Devices Market, by Country
7.1 China Mobile ECG Devices Market
7.1.1 China Mobile ECG Devices Market, by Modality
7.1.2 China Mobile ECG Devices Market, by End-use
7.2 Japan Mobile ECG Devices Market
7.2.1 Japan Mobile ECG Devices Market, by Modality
7.2.2 Japan Mobile ECG Devices Market, by End-use
7.3 India Mobile ECG Devices Market
7.3.1 India Mobile ECG Devices Market, by Modality
7.3.2 India Mobile ECG Devices Market, by End-use
7.4 South Korea Mobile ECG Devices Market
7.4.1 South Korea Mobile ECG Devices Market, by Modality
7.4.2 South Korea Mobile ECG Devices Market, by End-use
7.5 Singapore Mobile ECG Devices Market
7.5.1 Singapore Mobile ECG Devices Market, by Modality
7.5.2 Singapore Mobile ECG Devices Market, by End-use
7.6 Malaysia Mobile ECG Devices Market
7.6.1 Malaysia Mobile ECG Devices Market, by Modality
7.6.2 Malaysia Mobile ECG Devices Market, by End-use
7.7 Rest of Asia Pacific Mobile ECG Devices Market
7.7.1 Rest of Asia Pacific Mobile ECG Devices Market, by Modality
7.7.2 Rest of Asia Pacific Mobile ECG Devices Market, by End-use
Chapter 8. Company Profiles
8.1 New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group, PC)
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Nihon Kohden Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product Category and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.5.2 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 iRhythm Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Trials and Approvals:
8.5.5 SWOT Analysis
8.6 Koninklijke Philips N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 AliveCor, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Trials and Approvals:
8.8.3 SWOT Analysis
8.9 EMAY
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Nureca Limited (Dr Trust)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Recent strategies and developments:
8.10.3.1 Product Launches and Product Expansions:
8.10.4 SWOT Analysis
Unique Offerings 